Sub-population  ||| S:0 E:15 ||| JJ
analysis  ||| S:15 E:24 ||| NN
based  ||| S:24 E:30 ||| VBN
on  ||| S:30 E:33 ||| IN
temporal  ||| S:33 E:42 ||| JJ
features  ||| S:42 E:51 ||| NNS
of  ||| S:51 E:54 ||| IN
high  ||| S:54 E:59 ||| JJ
content  ||| S:59 E:67 ||| NN
images  ||| S:67 E:74 ||| NNS
High  ||| S:74 E:79 ||| JJ
content  ||| S:79 E:87 ||| NN
screening  ||| S:87 E:97 ||| NN
techniques  ||| S:97 E:108 ||| NNS
are  ||| S:108 E:112 ||| VBP
increasingly  ||| S:112 E:125 ||| RB
used  ||| S:125 E:130 ||| VBN
to  ||| S:130 E:133 ||| TO
understand  ||| S:133 E:144 ||| VB
the  ||| S:144 E:148 ||| DT
regulation  ||| S:148 E:159 ||| NN
and  ||| S:159 E:163 ||| CC
progression  ||| S:163 E:175 ||| NN
of  ||| S:175 E:178 ||| IN
cell  ||| S:178 E:183 ||| NN
motility ||| S:183 E:191 ||| NN
.  ||| S:191 E:193 ||| .
The  ||| S:193 E:197 ||| DT
demand  ||| S:197 E:204 ||| NN
of  ||| S:204 E:207 ||| IN
new  ||| S:207 E:211 ||| JJ
platforms ||| S:211 E:220 ||| NNS
,  ||| S:220 E:222 ||| ,
coupled  ||| S:222 E:230 ||| VBN
with  ||| S:230 E:235 ||| IN
availability  ||| S:235 E:248 ||| NN
of  ||| S:248 E:251 ||| IN
terabytes  ||| S:251 E:261 ||| NN
of  ||| S:261 E:264 ||| IN
data  ||| S:264 E:269 ||| NN
has  ||| S:269 E:273 ||| VBZ
challenged  ||| S:273 E:284 ||| VBN
the  ||| S:284 E:288 ||| DT
traditional  ||| S:288 E:300 ||| JJ
technique  ||| S:300 E:310 ||| NN
of  ||| S:310 E:313 ||| IN
identifying  ||| S:313 E:325 ||| VBG
cell  ||| S:325 E:330 ||| NN
populations  ||| S:330 E:342 ||| NNS
by  ||| S:342 E:345 ||| IN
manual  ||| S:345 E:352 ||| JJ
methods  ||| S:352 E:360 ||| NNS
and  ||| S:360 E:364 ||| CC
resulted  ||| S:364 E:373 ||| VBD
in  ||| S:373 E:376 ||| IN
development  ||| S:376 E:388 ||| NN
of  ||| S:388 E:391 ||| IN
high-dimensional  ||| S:391 E:408 ||| JJ
analytical  ||| S:408 E:419 ||| JJ
methods ||| S:419 E:426 ||| NNS
.  ||| S:426 E:428 ||| .
In  ||| S:428 E:431 ||| IN
this  ||| S:431 E:436 ||| DT
paper ||| S:436 E:441 ||| NN
,  ||| S:441 E:443 ||| ,
we  ||| S:443 E:446 ||| PRP
present  ||| S:446 E:454 ||| VBP
sub-populations  ||| S:454 E:470 ||| JJ
analysis  ||| S:470 E:479 ||| NN
of  ||| S:479 E:482 ||| IN
cells  ||| S:482 E:488 ||| NNS
at  ||| S:488 E:491 ||| IN
the  ||| S:491 E:495 ||| DT
tissue  ||| S:495 E:502 ||| NN
level  ||| S:502 E:508 ||| NN
by  ||| S:508 E:511 ||| IN
using  ||| S:511 E:517 ||| VBG
dynamic  ||| S:517 E:525 ||| JJ
features  ||| S:525 E:534 ||| NNS
of  ||| S:534 E:537 ||| IN
the  ||| S:537 E:541 ||| DT
cells ||| S:541 E:546 ||| NNS
.  ||| S:546 E:548 ||| .
We  ||| S:548 E:551 ||| PRP
used  ||| S:551 E:556 ||| VBD
active  ||| S:556 E:563 ||| JJ
contour  ||| S:563 E:571 ||| NN
without  ||| S:571 E:579 ||| IN
edges  ||| S:579 E:585 ||| NNS
for  ||| S:585 E:589 ||| IN
segmentation  ||| S:589 E:602 ||| NN
of  ||| S:602 E:605 ||| IN
cells ||| S:605 E:610 ||| NNS
,  ||| S:610 E:612 ||| ,
which  ||| S:612 E:618 ||| WDT
preserves  ||| S:618 E:628 ||| VBZ
the  ||| S:628 E:632 ||| DT
cell  ||| S:632 E:637 ||| NN
morphology ||| S:637 E:647 ||| NN
,  ||| S:647 E:649 ||| ,
and  ||| S:649 E:653 ||| CC
autoregressive  ||| S:653 E:668 ||| JJ
modeling  ||| S:668 E:677 ||| NN
to  ||| S:677 E:680 ||| TO
model  ||| S:680 E:686 ||| NN
cell  ||| S:686 E:691 ||| NN
trajectories ||| S:691 E:703 ||| NN
.  ||| S:703 E:705 ||| .
The  ||| S:705 E:709 ||| DT
sub-populations  ||| S:709 E:725 ||| NN
were  ||| S:725 E:730 ||| VBD
obtained  ||| S:730 E:739 ||| VBN
by  ||| S:739 E:742 ||| IN
clustering  ||| S:742 E:753 ||| JJ
static ||| S:753 E:759 ||| NN
,  ||| S:759 E:761 ||| ,
dynamic  ||| S:761 E:769 ||| JJ
and  ||| S:769 E:773 ||| CC
a  ||| S:773 E:775 ||| DT
combination  ||| S:775 E:787 ||| NN
of  ||| S:787 E:790 ||| IN
both  ||| S:790 E:795 ||| DT
features ||| S:795 E:803 ||| NNS
.  ||| S:803 E:805 ||| .
We  ||| S:805 E:808 ||| PRP
were  ||| S:808 E:813 ||| VBD
able  ||| S:813 E:818 ||| JJ
to  ||| S:818 E:821 ||| TO
identify  ||| S:821 E:830 ||| VB
three  ||| S:830 E:836 ||| CD
unique  ||| S:836 E:843 ||| JJ
sub-populations  ||| S:843 E:859 ||| NN
in  ||| S:859 E:862 ||| IN
combined  ||| S:862 E:871 ||| JJ
clustering ||| S:871 E:881 ||| NN
.  ||| S:881 E:883 ||| .
We  ||| S:883 E:886 ||| PRP
report  ||| S:886 E:893 ||| VBP
a  ||| S:893 E:895 ||| DT
novel  ||| S:895 E:901 ||| NN
method  ||| S:901 E:908 ||| NN
to  ||| S:908 E:911 ||| TO
identify  ||| S:911 E:920 ||| VB
sub-populations  ||| S:920 E:936 ||| JJ
using  ||| S:936 E:942 ||| VBG
kinetic  ||| S:942 E:950 ||| JJ
features  ||| S:950 E:959 ||| NNS
and  ||| S:959 E:963 ||| CC
demonstrate  ||| S:963 E:975 ||| VB
that  ||| S:975 E:980 ||| IN
these  ||| S:980 E:986 ||| DT
features  ||| S:986 E:995 ||| NNS
improve  ||| S:995 E:1003 ||| VBP
sub-population  ||| S:1003 E:1018 ||| JJ
analysis  ||| S:1018 E:1027 ||| NN
at  ||| S:1027 E:1030 ||| IN
the  ||| S:1030 E:1034 ||| DT
tissue  ||| S:1034 E:1041 ||| NN
level ||| S:1041 E:1046 ||| NN
.  ||| S:1046 E:1048 ||| .
These  ||| S:1048 E:1054 ||| DT
advances  ||| S:1054 E:1063 ||| NNS
will  ||| S:1063 E:1068 ||| MD
facilitate  ||| S:1068 E:1079 ||| VB
the  ||| S:1079 E:1083 ||| DT
application  ||| S:1083 E:1095 ||| NN
of  ||| S:1095 E:1098 ||| IN
high  ||| S:1098 E:1103 ||| JJ
content  ||| S:1103 E:1111 ||| NN
screening  ||| S:1111 E:1121 ||| NN
data  ||| S:1121 E:1126 ||| NNS
analysis  ||| S:1126 E:1135 ||| NN
to  ||| S:1135 E:1138 ||| TO
new  ||| S:1138 E:1142 ||| JJ
and  ||| S:1142 E:1146 ||| CC
complex  ||| S:1146 E:1154 ||| JJ
biological  ||| S:1154 E:1165 ||| JJ
problems ||| S:1165 E:1173 ||| NNS
.  ||| S:1173 E:1175 ||| .
